Aker BioMarine Announces New Research on Lysoveta's EPA and DHA Transfer to the Brain
NQ Score
80/100
N1 Content Completeness
80
AI Summary (NQ-processed)
Aker BioMarine, a leading company in sustainable marine-derived ingredients, has announced new research on its novel compound 'Lysoveta' and its role in facilitating the transfer of EPA and DHA to the brain. This research is part of the company's commitment to addressing global health challenges.